Abstract
Editorial: Reducing mortality from cardiovascular disease among patients undergoing dialysis is a global public health challenge. The past 10 years have seen trials of many interventions designed to improve survival and cardiovascular outcomes in these patients. Unfortunately, none of these interventions has been shown to be effective, despite beneficial effects in surrogate markers. It appears that statins have now joined this group of “promising but ineffective” interventions.
| Original language | English |
|---|---|
| Pages (from-to) | 1455-1457 |
| Number of pages | 3 |
| Journal | New England Journal of Medicine |
| Volume | 360 |
| Issue number | 14 |
| DOIs | |
| Publication status | Published - 2 Apr 2009 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Cardiovascular disease
- kidney disease
- dialysis
Fingerprint
Dive into the research topics of 'Sunset for statins after AURORA?'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver